A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Clinical trial NCT02974725 · TERMINATED
Trial details
- NCT number
- NCT02974725
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-24
- Primary completion
- 2024-04-24
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.